Effects of Shockwave Therapy Versus Ultrasound Therapy Among Patients With Chronic Sciatica

NCT07710924 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2026-07-17

No results posted yet for this study

Summary

Sciatica is characterized by radiating pain, functional limitations, reduced flexibility, disturbed sleep, and impaired quality of life. Extracorporeal Shockwave Therapy (ESWT) and Therapeutic Ultrasound are commonly used physiotherapy modalities for pain relief and tissue healing; however, evidence directly comparing their effectiveness remains limited. This randomized controlled trial compares the effects of Shockwave Therapy and Ultrasound Therapy, each combined with conventional physiotherapy, on pain intensity, hamstring range of motion, sleep quality, and quality of life in patients with chronic sciatica.

Conditions

  • Sciatica
  • Chronic Sciatica
  • Lumbar Radiculopathy

Interventions

DEVICE

Extracorporeal Shockwave Therapy

Radial extracorporeal shockwave therapy will be applied to the sciatic nerve origin and piriformis region using standardized treatment parameters for approximately 10 minutes during each treatment session.

DEVICE

Therapeutic Ultrasound

Therapeutic ultrasound will be applied to the gluteal and lumbar regions using standardized frequency and intensity parameters for approximately 10 minutes during each treatment session.

OTHER

Conventional Physiotherapy

Conventional physiotherapy will include moist heat therapy, myofascial release, stretching exercises, and strengthening exercises administered during every treatment session.

Sponsors & Collaborators

  • University of Lahore

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-30
Primary Completion
2026-03-10
Completion
2026-04-12

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07710924 on ClinicalTrials.gov